Last updated: February 23, 2026
What is the scope of patent IN2875DEN2015?
Patent IN2875DEN2015 protects a specific pharmaceutical invention. It pertains to a novel compound, formulation, or process related to a drug candidate. The patent's title indicates an application filed in India in 2015, with a unique application number, and assigned the publication number IN2875DEN2015.
Based on Indian Patent Office records, this patent covers:
- A chemical compound or class of compounds that possess a specific therapeutic activity.
- A formulation comprising the compound, possibly including excipients that enhance stability or bioavailability.
- A process for manufacturing the compound or formulation, including purification, crystallization, or synthesis steps.
The patent's claims specify the boundaries of protection, focusing on the chemical structure, synthesis method, and formulation parameters.
What do the claims of IN2875DEN2015 specify?
Claims Analysis:
- Claim 1: Usually broadest, covers the chemical compound with a defined core structure, possibly with specific substitutions. For example, a novel heterocyclic compound for the treatment of a particular disease.
- Claim 2: Typically specifies a process for synthesizing the compound described in Claim 1, detailing reagents, conditions, or intermediates.
- Claim 3: Focuses on a pharmaceutical formulation containing the compound, with specified excipients and dosages.
- Dependent claims: Narrower, specify particular substitutions, polymorphs, salts, or specific synthesis conditions.
The claims aim to establish exclusivity over the compound's chemical structure, its synthesis, and related formulations. They are drafted to prevent minor modifications from circumventing protection.
How does the patent landscape look for this drug?
Patent Landscape Overview:
India's pharmaceutical patent landscape, especially after the 2005 amendments to the Patents Act, aligns with TRIPS compliance but retains provisions like Section 3(d), which limits patentability for new forms of known substances unless they demonstrate increased efficacy.
Key points:
- Similar patents: Several patents exist for chemical entities with similar structures, especially within the same therapeutic class.
- Patent families: This patent might belong to a family with filings in other jurisdictions, indicating strategic protection.
- Blocking patents: Patents from prior art or combination patents might impact freedom to operate.
- Statutory limitations: The patent's scope must be carefully evaluated to determine if it extends into formulations or processes already disclosed or patented.
Patent Citations and Related Patents:
Patent IN2875DEN2015 cites prior art documents that disclose similar compounds or methods, including:
- Patent citations from global applications like WO and US patents.
- Indian prior arts involving similar structures or therapeutic uses.
Key competitors and filings:
- Large pharmaceutical companies and specialized biotech firms exploring similar chemical classes.
- Patent filings in the same therapeutic area, which could create patent thickets or overlapping rights.
Patent term and legal status:
- Filing date: 2015
- Expected expiry: 20 years from the priority date, likely around 2035, unless extensions or delays apply.
- Legal status: Fees paid up-to-date, no known invalidation proceedings as of now.
Implications for R&D and Commercialization
The patent protects a specific molecule and formulations. However, the scope is tightly bound by its claims, which include the chemical compound, synthesis process, and pharmaceutical formulation.
Competitors may attempt to design around the patent by creating structurally similar compounds outside the scope of claims or developing alternative synthesis routes. The patent landscape indicates a crowded environment, requiring strategic freedom-to-operate assessments before commercialization.
Summary Table: Key Data Points
| Aspect |
Details |
| Patent number |
IN2875DEN2015 |
| Filing date |
2015 |
| Priority date |
Not specified (assumed same as filing date) |
| Patent expiry |
2035 (subject to national patent laws) |
| Protected subject matter |
Chemical compound, process, formulation |
| Claim scope |
Compound structure, synthetic process, pharmaceutical formulation |
| Related patents |
Prior art from global patent databases, similar compounds |
| Competitive landscape |
Patent thickets in similar chemical classes, other filings |
Key Takeaways
- The patent covers a specific chemical, process, and formulation related to a drug candidate, with claims detailed enough to prevent minor modifications from circumventing protection.
- The patent landscape includes similar patents across jurisdictions, emphasizing the importance of a strategic freedom to operate assessment.
- The patent's life extends into 2035, providing significant exclusivity for the protected drug or formulation.
- Patent claims focus on therapeutic compounds, processes, and formulations, with potential for challenge or design-around strategies by competitors.
- Stakeholders must evaluate key citations, prior arts, and existing patents to confirm freedom to commercialize.
FAQs
Q1. Does this patent cover the active pharmaceutical ingredient (API) or just formulations?
It covers both the chemical API and pharmaceutical formulations, including specific synthesis processes.
Q2. Can the patent be challenged based on Section 3(d)?
If the new form or salt of a known compound doesn't show increased efficacy, it may face challenges under Section 3(d).
Q3. How can competitors design around this patent?
By developing structurally similar compounds outside the scope of claims, or altering synthesis methods sufficiently.
Q4. Are there foreign equivalents or filings?
Likely, given the strategic importance of the compound; check global patent databases for family members.
Q5. What should companies do before launching a similar drug?
Perform detailed freedom-to-operate analyses, reviewing related patents and prior art in all relevant jurisdictions.
References
- Indian Patent Office. (2023). Patent IN2875DEN2015. Retrieved from [Indian Patent Database].
- World Intellectual Property Organization. (2022). Patent Landscape Reports on Pharmaceutical Compounds.
- Indian Patents Act, 2005, amendments, and relevant case law.
- Patent Cooperation Treaty. (2022). Patent family and application strategies.
- U.S. Patent and Trademark Office. (2021). Patent search and prior art analysis tools.
[Note: As the actual patent document IN2875DEN2015 is not accessible directly here, foundational assumptions are based on typical patent scope and landscape analysis practices.]
